Sep 8, 2023

Featuring perspectives from Dr Corey J Langer, Dr Ticiana Leal, Dr Karen Reckamp and Dr Jacob Sands, including the following topics:

• Optimal use of front-line immune checkpoint inhibition for metastatic non-small cell lung cancer (NSCLC) (00:00)
• Case: A man in his late 60s with NSCLC, no actionable mutations, PD-L1...

Aug 22, 2023

Featuring perspectives from Dr Matthew Gubens, including the following topics:

• Investigator perspectives on emerging findings with immunotherapy for resectable non-small cell lung cancer (NSCLC) (0:00)
• Immunotherapy for early-stage unresectable disease (7:51)
• First-line therapy for patients with metastatic NSCLC with...

Aug 22, 2023

Featuring a slide presentation and related discussion from Dr Matthew Gubens, including the following topics:

• Early-stage non-small cell lung cancer (NSCLC) with an EGFR mutation (0:00)
• Management of metastatic NSCLC with an EGFR mutation (6:34)
• Prognostic and predictive implications of plasma circulating tumor DNA for...

Jun 20, 2023

Featuring perspectives from Dr Edward B Garon, Dr John V Heymach, Dr Corey J Langer, Dr Ticiana Leal, Dr David R Spigel and Dr Helena Yu, including the following topics:

• Incorporation of Immunotherapeutic Strategies into the Management of Nonmetastatic Non-Small Cell Lung Cancer (NSCLC)
  • Introduction (0:00)
  • Strategies...

May 22, 2023

Featuring perspectives from Dr Stephen V Liu, Ms Tara Plues, Ms Jillian Thompson and Dr Anne S Tsao, including the following topics:

• Introduction (0:00)
• Immunotherapy for Nonmetastatic and Metastatic Non-Small Cell Lung Cancer (NSCLC) (5:47)
• Future Directions — Tumor Treating Fields (37:30)
• Overview of...